Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Nicholas Teman to Anticoagulants

This is a "connection" page, showing publications Nicholas Teman has written about Anticoagulants.

 
Connection Strength
 
 
 
0.411
 
  1. Scott EJ, Rotar E, Dahl JJ, Beller JP, Money DT, Chancellor WZ, Mehaffey JH, Morisette M, Yarboro LT, Teman NR. Discordance among assays for monitoring? Anticoagulation during extracorporeal life support. Perfusion. 2023 11; 38(8):1714-1721.
    View in: PubMed
    Score: 0.138
  2. Norman AV, Teman NR. Commentary: Heparin-Induced Thrombocytopenia - Getting Ahead of the Game. Semin Thorac Cardiovasc Surg. 2022; 34(2):583-584.
    View in: PubMed
    Score: 0.126
  3. Beller JP, Krebs ED, Hawkins RB, Mehaffey JH, Quader MA, Speir AM, Kiser AC, Joseph M, Yarboro LT, Teman NR, Ailawadi G. Non-vitamin K oral anticoagulant use after cardiac surgery is rapidly increasing. J Thorac Cardiovasc Surg. 2020 11; 160(5):1222-1231.
    View in: PubMed
    Score: 0.112
  4. Mazzeffi M, Lin D, Gonzalez-Almada A, Stombaugh DK, Curley J, Mangunta V, Teman N, Yarboro LT, Thiele R. Outcomes of heparinized adult veno-arterial extracorporeal membrane oxygenation patients managed with low and high activated partial thromboplastin time targets: A systematic review and meta-analysis. Perfusion. 2024 04; 39(3):525-535.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)